MacroGenics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MacroGenics, Inc. (Nasdaq: MGNX) announced its participation in two key conferences in August 2021. The first event is the BTIG Virtual Biotechnology Conference on August 10, where management will engage in a fireside chat at 9:30 am ET and conduct one-on-one meetings. The second is the 12th Annual Wedbush PacGrow Healthcare Conference on August 11, featuring CEO Scott Koenig in a panel discussion titled ADCs – Take Me to Your Tumor at 2:20 pm ET, along with one-on-one meetings. Webcast access for these events is available on their website.

ROCKVILLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following conferences in August:

• BTIG Virtual Biotechnology Conference 2021.  MacroGenics’ management is scheduled to participate in a fireside chat on Tuesday, August 10, 2021, at 9:30 am ET live via webcast to conference attendees (not available for replay).  Management will also participate in one-on-one meetings.
• 12^th Annual Wedbush PacGrow Healthcare Conference.  MacroGenics’ President & Chief Executive Officer, Scott Koenig, M.D., Ph.D., will participate in a panel discussion, ADCs – Take Me to Your Tumor, on Wednesday, August 11, 2021, at 2:20 pm ET.  Management will also participate in one-on-one meetings.

A webcast of the August 11, 2021 panel discussion may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company maintains archived replays of webcasts on its website for 30 days after each conference.

About MacroGenics, Inc.
MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

###

FAQ

What events is MacroGenics participating in August 2021?

MacroGenics is participating in the BTIG Virtual Biotechnology Conference on August 10 and the 12th Annual Wedbush PacGrow Healthcare Conference on August 11, 2021.

What is the date and time of MacroGenics' fireside chat?

The fireside chat at the BTIG Virtual Biotechnology Conference is scheduled for August 10, 2021, at 9:30 am ET.

Who will represent MacroGenics at the Wedbush PacGrow Conference?

Scott Koenig, M.D., Ph.D., President & CEO of MacroGenics, will participate in a panel discussion at the Wedbush PacGrow Healthcare Conference.

What is the topic of the panel discussion at the Wedbush PacGrow Conference?

The panel discussion attended by MacroGenics' CEO is titled ADCs – Take Me to Your Tumor.

How can I access the webcasts of MacroGenics' conference presentations?

Webcasts of MacroGenics' conference presentations can be accessed under 'Events & Presentations' in the Investor Relations section of their website.